NYSE: ABBV - AbbVie

Yield per half year: -5.96%
Dividend yield: +3.43%
Sector: Healthcare

Share chart AbbVie

Extended chart Simple chart
Financial Markets by TradingView

About AbbVie

19 октября 2011 года Abbott Laboratories объявила о своем плане разделения на две публично торгуемые компании. » Новые " лаборатории Abbott будут специализироваться на разнообразных продуктах, включая медицинские приборы, диагностическое оборудование и продукты питания, в то время как AbbVie будет работать как фармацевтический производитель, основанный на исследованиях

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2013-01-02
ISIN US00287Y1091
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 3.56
Дивиденд ао 1.64
Сайт http://www.abbvie.com
Цена ао 179.1
Change price per day: 0% (179.1)
Change price per week: +1.95% (175.67)
Change price per month: -15.43% (211.77)
Change price per 3 month: +2.02% (175.55)
Change price per half year: -5.96% (190.46)
Change price per year: +10.78% (161.67)
Change price per 3 year: +16.97% (153.11)
Change price per 5 year: +63.07% (109.83)
Change price per 10 year: +166.92% (67.1)
Change price per year to date: +2% (175.58)
All parameters

Underestimation

Title Value Grade
P/S 5.55 2
P/BV 92.87 1
P/E 73.03 1
EV/EBITDA 25.09 4
Total: 5.38

Efficiency

Title Value Grade
ROA, % 3.17 1
ROE, % 62.52 10
Total: 6

Dividends

Title Value Grade
Div yield, % 3.43 8.58
DSI 0.9286 9.29
Total: 7.97

Debt

Title Value Grade
Debt/EBITDA 4.5 1
Total: 2.6

Growth impulse

Title Value Grade
Yield Revenue, % 23 4
Yield Ebitda, % 114.53 10
Yield EPS, % -12.58 0
Total: 3.2
More

More

Institutions Volume Share, %
Vanguard Group Inc 160398331 9.06
Blackrock Inc. 143182709 8.09
State Street Corporation 78200866 4.42
JP Morgan Chase & Company 51818311 2.93
Capital International Investors 44988183 2.54
Geode Capital Management, LLC 37017486 2.09
Morgan Stanley 34052535 1.92
Capital Research Global Investors 30302654 1.71
Charles Schwab Investment Management, Inc. 24451975 1.38
Bank Of New York Mellon Corporation 22104491 1.25

ETFShare, %Profitability for 1 year, %Dividends, %
MicroSectors Cannabis 2X Leveraged ETN 9.44 88.65
iShares Evolved U.S. Innovative Healthcare ETF 5.87 0.000586 2.79
AdvisorShares Vice ETF 4.32 21.94 2.27
2nd Vote Society Defended ETF 4.15 0 1.16
AVDR U.S. LargeCap ESG ETF 4.08 0
Apex Healthcare ETF 4.02 0
Vesper U.S. Large Cap Short-Term Reversal Strategy ETF 3.98632 37.39 2.11893
UPHOLDINGS Compound Kings ETF 3.95159 9.66
John Hancock Multifactor Healthcare ETF 3.24 29.34 1.62
Donoghue Forlines Innovation ETF 3.21601 10.06 0.89556
Global X Longevity Thematic ETF 3.16 4.72 0.36
iShares Evolved U.S. Healthcare Staples ETF 3.03 31.23 0.71
FCF US Quality ETF 2.88582 18.99 1.58997
BNY Mellon Sustainable US Equity ETF 2.53 0 0.66
Franklin U.S. Low Volatility ETF 2.34765 5.95 3.14623
FlexShares Quality Dividend Dynamic Index Fund 1.94 33.57 2.42
Trajan Wealth Income Opportunities ETF 1.93117 9.59 4.43043
ETRACS Monthly Pay 2xLeveraged S&P Dividend ETN 1.39 0 1.57
iShares Factors US Blend Style ETF 1.33 44.21 1.31
iShares Morningstar Large-Cap Value ETF 1.31728 63.82 2.17567
US Equity Dividend Select ETF 1.27011 -2.35 3.20163
Invesco Defensive Equity ETF 1.08 -1.05 1.45
Tactical Income ETF 0.97 0 2.43
Principal US Large-Cap Adaptive Multi-Factor ETF 0.85 0 1.42
iShares Morningstar Large-Cap ETF 0.68025 257.57 1.41244
Fidelity New Millennium ETF 0.64952 -2.96 1.58241
Columbia U.S. ESG Equity Income ETF 0.60155 -99.18 1.44131
JPMorgan Corporate Bond Research Enhanced ETF 0.13 6.26 4.16
2.6620.261.65



Head Job title Payment Year of birth
Mr. Richard A. Gonzalez Executive Chairman 7.19M 1954 (71 year)
Mr. Robert A. Michael CEO & Director 4.62M 1970 (55 years)
Ms. Elizabeth Shea Senior Vice President of Investor Relations N/A
Mr. Timothy J. Richmond Executive VP & Chief Human Resources Officer 1.12M 1966 (59 years)
Mr. Jeffrey Ryan Stewart Executive VP & Chief Commercial Officer 4.32M 1969 (56 years)
Dr. Azita Saleki-Gerhardt Ph.D. Executive VP & COO 3.51M 1963 (62 years)
Mr. Scott T. Reents Executive VP & CFO 3.13M 1968 (57 years)
Mr. Sanjay Narayan Senior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic Legal N/A
Mr. Perry C. Siatis Executive VP, General Counsel & Secretary N/A 1975 (50 years)
Dr. Roopal Thakkar M.D. Executive VP of Research and Development & Chief Scientific Officer 1972 (53 years)

Address: United States, North Chicago, 1 North Waukegan Road - open in Google maps, open in Yandex maps
Website: http://www.abbvie.com